249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions.
Pharmacies and pharmacists continue to play a vital role in getting shots to arms and urging those individuals who have not yet received a COVID-19 vaccine to roll up their sleeves and get vaccinated.
On May 19, NACDS submitted a statement to the U.S. Senate Committee on Finance for a hearing entitled, “COVID-19 Health Care Flexibilities: Perspectives, Experiences, and Lessons Learned.”
Urges Congress to pass legislation to reduce patients’ out-of-pocket costs and to prevent pharmacy closures jeopardizing patient access.
As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care
Last week, the virtual NACDS Annual Meeting honored NACDS chain and supplier members for empowering America’s response to and recovery from the COVID-19 pandemic.
NAB President & CEO Emphasizes Trust of Pharmacists in Senate Subcommittee Hearing.
Letter to Administration salutes President Biden’s leadership, urges vaccine allocation to pharmacies sufficient for “allowing individuals to stay in their local neighborhoods when scheduling a vaccination appointment.”
On Wednesday, March 24, the Congressional Hispanic Caucus (CHC) COVID-19 task force met with NACDS member pharmacies.
The NACDS RxIMPACT grassroots advocacy program announced several grassroots recognitions during the Virtual 2021 NACDS RxIMPACT Day on Capitol Hill opening program on Thursday, March 4.
In addition to the ground-breaking event’s critical importance in advocating for pro-patient, pro-pharmacy priorities, the 2021 program also served as the virtual venue for the announcement of four awards and the recognition of seven Pioneers.
This year, NACDS presented the 2020 and 2021 NACDS RxIMPACT Key Contact of the Year Awards. The 2020 awards were presented this year given that the 2020 event could not be held due to the onset of the COVID-19 pandemic which closed Capitol Hill offices.
The first two awards went to Randy Edeker, president and CEO of Hy-Vee, Inc., past NACDS chairman and current NACDS Board of Directors member, who received the 2020 NACDS RxIMPACT Key Contact of the Year Award; and Lynne Fruth, president of Fruth Pharmacy and current NACDS Board of Directors member, who earned the 2021 NACDS RxIMPACT Key Contact of the Year award.
The Key Contact Award recognizes pharmacy advocates who actively engage with members of Congress on pro-pharmacy legislative priorities.
Edeker distinguished himself through his commitment to raising awareness among Members of Congress and the federal executive branch about the critical need for direct and indirect remuneration (DIR) fee reform. Edeker is highly engaged in NACDS RxIMPACT activities, and has organized various pharmacy tours at Hy-Vee with national leaders. Edeker’s passion for DIR free reform continues to inspire action among pharmacy advocates and key legislators alike.
Fruth was recognized for her dedication to serving as a voice of the industry and for consistently engaging with key federal and state legislators on critical pharmacy issues that directly impact pharmacy value and viability, such as DIR fee reform and 340B. For over a decade, Fruth has actively participated in nearly 100 NACDS RxIMPACT Day on Capitol Hill meetings and has led myriad Congressional pharmacy tours at Fruth Pharmacy. Fruth and her team were recently recognized by Sen. Joe Manchin (D-WV) for their dedication to getting COVID-19 vaccinations to West Virginia communities.
NACDS also presented the 2020 and 2021 NACDS RxIMPACT Leader of the Year Awards – a recognition [ READ MORE ]
